Difference between revisions of "Part:BBa K404127:Design"
 
Line 14: Line 14:
  
 
===References===
 
===References===
 +
<b>Danckwardt, S., Hentze, M.W. & Kulozik, A.E.</b>, 2008. 3' end mRNA processing: molecular mechanisms and implications for health and disease. The EMBO journal, 27(3), 482-98. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18256699.<br>
 +
<b>Millevoi, S. et al.</b>, 2006. An interaction between U2AF 65 and CF I(m) links the splicing and 3' end processing machineries. The EMBO journal, 25(20), 4854-64. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17024186.<br>

Latest revision as of 03:47, 25 October 2010

[AAV2]-left-ITR_pCMV_betaglobin_mVenus_[AAV2]-right-ITR


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 1319
    Illegal AgeI site found at 2039
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

Assembled vectorplasmid of BioBricks missing the hGH termiantion signal.


Source

Assembled vectorplasmid of BioBricks.

References

Danckwardt, S., Hentze, M.W. & Kulozik, A.E., 2008. 3' end mRNA processing: molecular mechanisms and implications for health and disease. The EMBO journal, 27(3), 482-98. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18256699.
Millevoi, S. et al., 2006. An interaction between U2AF 65 and CF I(m) links the splicing and 3' end processing machineries. The EMBO journal, 25(20), 4854-64. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17024186.